ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [11/20/2025 16:30 PST] ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Down By 100% ($84.55) From $84.55 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [11/14/2025 06:50 PST] ANIP Expected to Trade Down Short Term
• [11/10/2025 07:40 PST] ANIP Expected to Trade Up After Bullish Patterns Develop
• [11/07/2025 10:29 PST] ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), Down By 100% ($95.8) From $95.8 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [10/24/2025 07:32 PDT] ANIP Expected to Trade Down After Bearish Patterns Develop
• [10/21/2025 07:13 PDT] ANIP Expected to Trade Up After Bullish Patterns Develop
• [10/16/2025 07:08 PDT] ANIP Expected to Trade Up Short Term